Drug Type AAV based gene therapy |
Synonyms |
Target |
Action modulators |
Mechanism podocin modulators(NPHS2 stomatin family member, podocin modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nephrotic Syndrome | Preclinical | United Kingdom | 01 Apr 2025 |